(NASDAQ: SLGL) Sol Gel Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.51%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.17%.
Sol Gel Technologies's earnings in 2026 is -$1,046,000.On average, 4 Wall Street analysts forecast SLGL's earnings for 2026 to be -$19,606,100, with the lowest SLGL earnings forecast at -$21,816,592, and the highest SLGL earnings forecast at -$16,990,581. On average, 3 Wall Street analysts forecast SLGL's earnings for 2027 to be -$16,505,136, with the lowest SLGL earnings forecast at -$15,857,875, and the highest SLGL earnings forecast at -$16,990,581.
In 2028, SLGL is forecast to generate -$11,670,298 in earnings, with the lowest earnings forecast at -$11,212,639 and the highest earnings forecast at -$12,013,542.